Progyny (NASDAQ:PGNY) Issues Q4 2024 Earnings Guidance

Progyny (NASDAQ:PGNY) updated its fourth quarter 2024 earnings guidance on Tuesday. The company provided EPS guidance of 0.310-0.350 for the period, compared to the consensus EPS estimate of 0.140. The company issued revenue guidance of $266.2 million-$281.2 million, compared to the consensus revenue estimate of $292.7 million. Progyny also updated its FY 2024 guidance to 1.540-1.570 EPS.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the stock. Truist Financial reduced their price objective on shares of Progyny from $33.00 to $26.00 and set a “buy” rating on the stock in a research note on Thursday, September 19th. Canaccord Genuity Group reduced their price objective on shares of Progyny from $24.00 to $18.00 and set a “hold” rating on the stock in a research note on Friday, September 20th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $25.00 price target on shares of Progyny in a research note on Tuesday, October 1st. Leerink Partnrs downgraded shares of Progyny from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 7th. Finally, Jefferies Financial Group cut their price target on shares of Progyny from $31.00 to $24.00 and set a “buy” rating on the stock in a research note on Thursday, September 19th. Seven research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $27.73.

Progyny Price Performance

PGNY traded up $0.12 during trading hours on Tuesday, reaching $17.18. 1,996,870 shares of the stock traded hands, compared to its average volume of 1,371,571. The firm’s fifty day simple moving average is $18.01 and its two-hundred day simple moving average is $23.73. The company has a market cap of $1.55 billion, a price-to-earnings ratio of 27.27, a PEG ratio of 1.57 and a beta of 1.44. Progyny has a fifty-two week low of $13.93 and a fifty-two week high of $42.08.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.